APLT vs TECH · rev $455.0K vs P/E 65, rev $1.22B
Applied Therapeutics Inc (APLT) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Applied Therapeutics Inc (APLT) is a biotechnology company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported APLT revenue for 2024-12-31 was $455.0K. Net income was -$105.6M. APLT currently screens at market cap $14.9M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
APLT currently screens at market cap $14.9M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the APLT and TECH stock pages for the full models.
Not investment advice.